Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 90603915 | FILING DATE | 03/25/2021 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | HSU, FONG |
L.O. ASSIGNED | O20-NOT FOUND |
PUB INFORMATION |
|||
RUN DATE | 01/18/2022 | ||
PUB DATE | N/A | ||
STATUS | 647-EXAMINERS AMENDMENT - MAILED | ||
STATUS DATE | 01/15/2022 | ||
LITERAL MARK ELEMENT | KRAZATI | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | KRAZATI |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | Mirati Therapeutics, Inc. |
ADDRESS | 3545 Cray Court San Diego, CA 92121 |
ENTITY | 03-CORPORATION |
CITIZENSHIP | Delaware |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors |
INTERNATIONAL CLASS | 042 |
DESCRIPTION TEXT | research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
01/15/2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | 017 |
01/15/2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 016 |
01/15/2022 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | 015 |
01/15/2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | 014 |
12/20/2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 013 |
12/20/2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 012 |
12/20/2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 011 |
11/09/2021 | ALIE | A | ASSIGNED TO LIE | 010 |
11/08/2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 009 |
11/08/2021 | GNRT | F | NON-FINAL ACTION E-MAILED | 008 |
11/08/2021 | CNRT | R | NON-FINAL ACTION WRITTEN | 007 |
11/01/2021 | DOCK | D | ASSIGNED TO EXAMINER | 006 |
07/01/2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 005 |
06/30/2021 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 004 |
06/30/2021 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | 003 |
06/30/2021 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | 002 |
03/29/2021 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | Eric R. Moran |
CORRESPONDENCE ADDRESS | ERIC R. MORAN MCDONNELL BOEHNEN HULBERT & BERGHOFF LLP 300 SOUTH WACKER DRIVE 31ST FLOOR CHICAGO, IL 60606 |
DOMESTIC REPRESENTATIVE | NONE |